H. Dienes, C. Gerharz, and R. Wagner, Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension, Journal of Hepatology, vol.3, issue.2, pp.223-230, 1986.
DOI : 10.1016/S0168-8278(86)80030-7

G. Lehmann, F. Asskali, and M. Boll, HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly, British Journal of Anaesthesia, vol.98, issue.5, pp.635-679, 2007.
DOI : 10.1093/bja/aem068

M. Dehne, J. Muhling, and A. Sablotzki, Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment, Journal of Clinical Anesthesia, vol.13, issue.2, pp.103-114, 2001.
DOI : 10.1016/S0952-8180(01)00225-2

C. Jungheinrich, R. Scharpf, and M. Wargenau, The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment, Anesth Analg, vol.95, pp.544-51, 2002.

J. Treib, J. Baron, M. Grauer, and R. Strauss, An international view of hydroxyethyl starches, Intensive Care Medicine, vol.25, issue.3, pp.258-68, 1999.
DOI : 10.1007/s001340050833

R. Trof, S. Sukul, and J. Twisk, Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia, Intensive Care Medicine, vol.37, issue.4, pp.697-701
DOI : 10.1007/s00134-010-1776-x

M. Miletin, T. Stewart, and P. Norton, Influences on physicians' choices of intravenous colloids, Intensive Care Medicine, vol.28, issue.7, pp.917-941, 2002.
DOI : 10.1007/s00134-002-1337-z

F. Schortgen, N. Deye, and L. Brochard, Preferred plasma volume expanders for critically ill patients: results of an international survey, Intensive Care Medicine, vol.87, issue.12, pp.2222-2231, 2004.
DOI : 10.1007/s00134-004-2415-1

J. Treib, A. Haass, and G. Pindur, Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration, Haemostasis, vol.26, pp.210-213, 1996.

J. Treib, A. Haass, and G. Pindur, All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation, Transfusion, vol.36, issue.5, pp.450-455, 1996.
DOI : 10.1046/j.1537-2995.1996.36596282590.x

C. Huraux, A. Ankri, and D. Eyraud, Hemostatic Changes in Patients Receiving Hydroxyethyl Starch: The Influence of ABO Blood Group, Anesthesia and Analgesia, vol.92, pp.1396-401, 2001.
DOI : 10.1097/00000539-200106000-00007

C. Hartog, D. Reuter, and W. Loesche, Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review, Intensive Care Medicine, vol.104, issue.11, pp.1725-1762
DOI : 10.1007/s00134-011-2385-z

G. Huet, R. Siemons, A. Baus, and D. , A novel hydroxyethyl starch (Voluven??) for effective perioperative plasma volume substitution in cardiac surgery, Canadian Journal of Anesthesia, vol.11, issue.12, pp.1207-1222, 2000.
DOI : 10.1007/BF03019870

O. Langeron, M. Doelberg, and E. Ang, Voluven??, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5, Anesthesia and Analgesia, vol.92, pp.855-62, 2001.
DOI : 10.1097/00000539-200104000-00011

F. Schortgen, E. Girou, N. Deye, and L. Brochard, The risk associated with hyperoncotic colloids in patients with shock, Intensive Care Medicine, vol.363, issue.Suppl 17, pp.2157-68, 2008.
DOI : 10.1007/s00134-008-1225-2

C. Legendre, E. Thervet, and B. Page, Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation, The Lancet, vol.342, issue.8865, pp.248-257, 1993.
DOI : 10.1016/0140-6736(93)92345-T

M. Dickenmann, T. Oettl, and M. Mihatsch, Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes, American Journal of Kidney Diseases, vol.51, issue.3, pp.491-503, 2008.
DOI : 10.1053/j.ajkd.2007.10.044

M. Cittanova, I. Leblanc, and C. Legendre, Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients, The Lancet, vol.348, issue.9042, pp.1620-1622, 1996.
DOI : 10.1016/S0140-6736(96)07588-5

F. Hokema, S. Ziganshyna, and M. Bartels, Is perioperative low molecular weight hydroxyethyl starch infusion a risk factor for delayed graft function in renal transplant recipients?, Nephrology Dialysis Transplantation, vol.26, issue.10, pp.3373-3381
DOI : 10.1093/ndt/gfr017

V. Blasco, M. Leone, and F. Antonini, Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation, British Journal of Anaesthesia, vol.100, issue.4, pp.504-512, 2008.
DOI : 10.1093/bja/aen001

F. Brunkhorst, C. Engel, and F. Bloos, Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis, New England Journal of Medicine, vol.358, issue.2, pp.125-164, 2008.
DOI : 10.1056/NEJMoa070716

I. Davidson, Renal impact of fluid management with colloids: a comparative review, European Journal of Anaesthesiology, vol.23, issue.9, pp.721-759, 2006.
DOI : 10.1017/S0265021506000639

C. Wiedermann, Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis, BMC Emergency Medicine, vol.64, issue.Suppl 2, 2008.
DOI : 10.1046/j.1523-1755.2003.00186.x

F. Schortgen, J. Lacherade, and F. Bruneel, Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study, The Lancet, vol.357, issue.9260, pp.911-917, 2001.
DOI : 10.1016/S0140-6736(00)04211-2

D. Rittoo, P. Gosling, and M. Simms, The Effects of Hydroxyethyl Starch Compared with Gelofusine on Activated Endothelium and the Systemic Inflammatory Response Following Aortic Aneurysm Repair, European Journal of Vascular and Endovascular Surgery, vol.30, issue.5, pp.520-524, 2005.
DOI : 10.1016/j.ejvs.2005.04.046

Y. Sakr, D. Payen, and K. Reinhart, Effects of hydroxyethyl starch administration on renal function in critically ill patients, British Journal of Anaesthesia, vol.98, issue.2, pp.216-240, 2007.
DOI : 10.1093/bja/ael333

L. Muller, S. Jaber, and N. Molinari, Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock, Critical Care, vol.16, issue.1, p.34
DOI : 10.1097/01.CCM.0000194725.48928.3A

URL : https://hal.archives-ouvertes.fr/hal-01137076

K. Reinhart, A. Perner, and C. Sprung, Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients, Intensive Care Medicine, vol.37, issue.6, pp.368-83
DOI : 10.1007/s00134-012-2472-9

M. Laxenaire, C. Charpentier, and L. Feldman, R??actions anaphylacto??des aux substituts collo??daux du plasma : incidence, facteurs de risque, m??canismes, Annales Fran??aises d'Anesth??sie et de R??animation, vol.13, issue.3, pp.301-311, 1994.
DOI : 10.1016/S0750-7658(94)80038-3

C. Mangano, L. Diamondstone, and J. Ramsay, Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource Utilization, Annals of Internal Medicine, vol.128, issue.3, pp.194-203, 1998.
DOI : 10.7326/0003-4819-128-3-199802010-00005

P. Conlon, M. Stafford-smith, and W. White, Acute renal failure following cardiac surgery, Nephrology Dialysis Transplantation, vol.14, issue.5, pp.1158-62, 1999.
DOI : 10.1093/ndt/14.5.1158

G. Chertow, E. Levy, and K. Hammermeister, Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery 11Access the ???Journal Club??? discussion of this paper at http://www.elsevier.com/locate/ajmselect/22The VA Continuous Improvement in Cardiac Surgery Program was initially supported by the Health Services Research and Development Service, Veterans Health Administration, and funded through VA Patient Care Services., The American Journal of Medicine, vol.104, issue.4, pp.343-351, 1998.
DOI : 10.1016/S0002-9343(98)00058-8

F. Ryckwaert, G. Boccara, J. Frappier, and P. Colson, Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery*, Critical Care Medicine, vol.30, issue.7, pp.1495-1503, 2002.
DOI : 10.1097/00003246-200207000-00016

W. Cooper, O. Brien, S. Thourani, and V. , Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery: Results From the Society of Thoracic Surgeons National Adult Cardiac Database, Circulation, vol.113, issue.8, pp.1063-70, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.580084

B. Loef, A. Epema, and T. Smilde, Immediate Postoperative Renal Function Deterioration in Cardiac Surgical Patients Predicts In-Hospital Mortality and Long-Term Survival, Journal of the American Society of Nephrology, vol.16, issue.1, pp.195-200, 2005.
DOI : 10.1681/ASN.2003100875

C. Hobson, S. Yavas, and M. Segal, Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery, Circulation, vol.119, issue.18, pp.2444-53, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.800011

C. Thakar, S. Worley, and S. Arrigain, Influence of renal dysfunction on mortality after cardiac surgery: Modifying effect of preoperative renal function, Kidney International, vol.67, issue.3, pp.1112-1121, 2005.
DOI : 10.1111/j.1523-1755.2005.00177.x

A. Lassnigg, E. Schmid, and M. Hiesmayr, Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: Do we have to revise current definitions of acute renal failure?*, Critical Care Medicine, vol.36, issue.4, pp.1129-1166, 2008.
DOI : 10.1097/CCM.0b013e318169181a

M. Rosner and M. Okusa, Acute Kidney Injury Associated with Cardiac Surgery, Clinical Journal of the American Society of Nephrology, vol.1, issue.1, pp.19-32, 2006.
DOI : 10.2215/CJN.00240605

C. Hartog and K. Reinhart, CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients, Intensive Care Medicine, vol.50, issue.8, pp.1337-1379, 2009.
DOI : 10.1007/s00134-009-1521-5

J. Rioux, M. Lessard, D. Bortoli, and B. , Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery*, Critical Care Medicine, vol.37, issue.4, pp.1293-1301, 2009.
DOI : 10.1097/CCM.0b013e31819cc1a0

W. Winkelmayer, R. Glynn, R. Levin, and J. Avorn, Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery, Kidney International, vol.64, issue.3, pp.1046-1055, 2003.
DOI : 10.1046/j.1523-1755.2003.00186.x

I. Davidson, Deleterious renal effects of hydroxyethyl starch 130/0.4 and 200/0.5 solutions, European Journal of Anaesthesiology, vol.24, issue.10, pp.892-895, 2007.
DOI : 10.1017/S0265021507000786

P. Perel and I. Roberts, Colloids versus crystalloids for fluid resuscitation in critically ill patients, Cochrane Database Syst Rev, p.567

I. Roberts, P. Alderson, and F. Bunn, Colloids versus crystalloids for fluid resuscitation in critically ill patients, Cochrane Database Syst Rev, vol.316, issue.22, p.567, 2004.
DOI : 10.1002/14651858.CD000567.pub2

F. Bunn, P. Alderson, and V. Hawkins, Colloid solutions for fluid resuscitation, Cochrane Database Syst Rev, p.1319, 2000.

D. Wijeysundera, K. Karkouti, and W. Beattie, Improving the Identification of Patients at Risk of Postoperative Renal Failure after Cardiac Surgery, Anesthesiology, vol.104, issue.1, pp.65-72, 2006.
DOI : 10.1097/00000542-200601000-00012

N. Schwann, J. Horrow, and M. Strong, Does Off-Pump Coronary Artery Bypass Reduce the Incidence of Clinically Evident Renal Dysfunction After Multivessel Myocardial Revascularization?, Anesthesia & Analgesia, vol.99, issue.4, pp.959-64, 2004.
DOI : 10.1213/01.ANE.0000132978.32215.2C

K. Karkouti, D. Wijeysundera, and T. Yau, Influence of Erythrocyte Transfusion on the Risk of Acute Kidney Injury after Cardiac Surgery Differs in Anemic and Nonanemic Patients, Anesthesiology, vol.115, issue.3, pp.523-553
DOI : 10.1097/ALN.0b013e318229a7e8

F. Schabinski, J. Oishi, and F. Tuche, Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients, Intensive Care Medicine, vol.72, issue.Suppl 1, pp.1539-1586, 2009.
DOI : 10.1007/s00134-009-1509-1

R. Bellomo, J. Kellum, and C. Ronco, Acute renal failure: time for consensus, Intensive Care Medicine, vol.132, issue.11, pp.1685-1693, 2001.
DOI : 10.1007/s00134-001-1120-6

A. Ahlstrom, A. Kuitunen, and S. Peltonen, Comparison of 2 Acute Renal Failure Severity Scores to General Scoring Systems in the Critically Ill, American Journal of Kidney Diseases, vol.48, issue.2, pp.262-270, 2006.
DOI : 10.1053/j.ajkd.2006.04.086

T. Niemi, A. Schramko, and A. Kuitunen, Haemodynamics and Acid-Base Equilibrium after Cardiac Surgery: Comparison of Rapidly Degradable Hydroxythyl Starch Solutions and Albumin, Scandinavian Journal of Surgery, vol.350, issue.3, pp.259-65, 2008.
DOI : 10.1139/y83-207

C. Jungheinrich, W. Sauermann, F. Bepperling, and N. Vogt, Volume Efficacy and Reduced Influence on Measures of Coagulation Using Hydroxyethyl Starch 130/0.4 (6%) with an Optimised in???Vivo???Molecular Weight in Orthopaedic Surgery, Drugs in R & D, vol.92, issue.1, pp.1-9, 2004.
DOI : 10.2165/00126839-200405010-00001

M. James, M. Latoo, and M. Mythen, Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers, Anaesthesia, vol.82, issue.18, pp.738-780, 2004.
DOI : 10.1046/j.1537-2995.1996.36596282590.x

D. Gattas, A. Dan, and J. Myburgh, Fluid Resuscitation with 6% Hydroxyethyl Starch (130/0.4) in Acutely Ill Patients, Anesthesia & Analgesia, vol.114, issue.1, pp.159-69
DOI : 10.1213/ANE.0b013e318236b4d6

M. Schick, T. Isbary, and N. Schlegel, The impact of crystalloid and colloid infusion on the kidney in rodent sepsis, Intensive Care Medicine, vol.51, issue.17, 2009.
DOI : 10.1007/s00134-009-1704-0

J. Waitzinger, F. Bepperling, and G. Pabst, Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers, Clinical Drug Investigation, vol.16, issue.2, pp.151-60, 1998.
DOI : 10.2165/00044011-199816020-00008

M. Leacche, W. Winkelmayer, and S. Paul, Predicting Survival in Patients Requiring Renal Replacement Therapy After Cardiac Surgery, The Annals of Thoracic Surgery, vol.81, issue.4, pp.1385-92, 2006.
DOI : 10.1016/j.athoracsur.2005.10.009

J. Myburgh, Q. Li, and S. Heritier, Statistical analysis plan for the Crystalloid Versus Hydroxyethyl Starch Trial (CHEST) Crit Care Resusc, p.52

A. Perner, N. Haase, and J. Wetterslev, Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial, Trials, vol.270, issue.1, p.24
DOI : 10.1001/jama.1993.03510240069035